<unk> (18F) is a radioactive diagnostic agent for adults with cognitive impairment who are being evaluated for Alzheimer's disease. It is indicated for positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs), a primary marker of Alzheimer's disease.<unk> (18F) is not indicated for use in the evaluation of people for chronic traumatic encephalopathy (CTE).
Flortaucipir 
Liraglutide
Linagliptin
Ulipristal acetate
Glimepiride
Lobeglitazone
Saxagliptin
Exenatide